{"date":"2026-06-11","count":35,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6876-2026-06-11-2319-f75d83","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"23:19:45","subject":"代子公司LAUNXP INTERNATIONAL CO., LTD.公告接獲Apollomics Inc. 合作暨授權協議終止通知","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-06-11 23:19，「代子公司LAUNXP INTERNATIONAL CO., LTD.公告接獲Apollomics Inc. 合作暨授權協」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-06-11-1914-fyx5vc","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"19:14:02","subject":"本公司受邀參加華南永昌證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-06-11 19:14，「本公司受邀參加華南永昌證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-11-1820-1b79d2s","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"18:20:38","subject":"董事會決議發行第一次海外無擔保可轉換公司債","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-11 18:20，「董事會決議發行第一次海外無擔保可轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-06-11-1714-4slwej","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"17:14:38","subject":"代重要子公司福爾聯合股份有限公司公告決議股利分派","clause":"第14款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-06-11 17:14，「代重要子公司福爾聯合股份有限公司公告決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-06-11-1702-1g4vjv4","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"17:02:06","subject":"公告本公司訂定115年除息除權基準日","clause":"第14款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-06-11 17:02，「公告本公司訂定115年除息除權基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-06-11-1656-1l7s7ts","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"16:56:50","subject":"公告本公司第四次買回庫藏股執行結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-06-11 16:56，「公告本公司第四次買回庫藏股執行結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-06-11-1615-qcjwao","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"16:15:29","subject":"代子公司PT All Cosmos Indonesia公告董事變動達三分之一","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-06-11 16:15，「代子公司PT All Cosmos Indonesia公告董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-06-11-1610-l3e6i7","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"16:10:51","subject":"本公司115年股東常會通過解除董事競業禁止之限制。","clause":"第22款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-06-11 16:10，「本公司115年股東常會通過解除董事競業禁止之限制。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-06-11-1610-p67uuk","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"16:10:38","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-06-11 16:10，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-06-11-1610-zk0qd9","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"16:10:25","subject":"公告本公司115年股東常會重要決議事項。","clause":"第15款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-06-11 16:10，「公告本公司115年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-06-11-1606-jflio5","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"16:06:27","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-06-11 16:06，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-06-11-1552-16106y9","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:52:17","subject":"公告本公司115年股東常會通過解除董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-06-11 15:52，「公告本公司115年股東常會通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-06-11-1551-3il1nf","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:51:44","subject":"公告本公司115年度股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-06-11 15:51，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-06-11-1539-lewzru","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"15:39:55","subject":"公告本公司2026年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-06-11 15:39，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-06-11-1531-1ttxab8","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:31:10","subject":"公告本公司董事會決議重新委任併購特別委員會委員","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-06-11 15:31，「公告本公司董事會決議重新委任併購特別委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-06-11-1529-lr5b7s","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:29:54","subject":"公告本公司董事會決議委任第七屆薪資報酬委員會委員並選任召集人","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-06-11 15:29，「公告本公司董事會決議委任第七屆薪資報酬委員會委員並選任召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-06-11-1529-1x0tnrc","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:29:03","subject":"公告本公司董事會決議永續發展委員會委員","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-06-11 15:29，「公告本公司董事會決議永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-06-11-1523-1euis3f","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:23:23","subject":"公告本公司第一屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-06-11 15:23，「公告本公司第一屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-06-11-1522-404p2v","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:22:30","subject":"公告本公司第二屆審計委員會委員","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-06-11 15:22，「公告本公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-06-11-1521-s0kpz3","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:21:39","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-06-11 15:21，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-06-11-1520-1076a2y","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:20:33","subject":"公告本公司115年度股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-06-11 15:20，「公告本公司115年度股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-06-11-1519-1jb8ii5","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"15:19:28","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-06-11 15:19，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-06-11-1517-1jb8ii5","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:17:43","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-06-11 15:17，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-06-11-1511-1cccuo4","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:11:36","subject":"公告本公司董事長訂定除息基準日","clause":"第14款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-06-11 15:11，「公告本公司董事長訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-06-11-1506-wuzkv0","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:06:09","subject":"公告本公司股東常會決議解除董事及其代表人競業禁止限制","clause":"第21款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-06-11 15:06，「公告本公司股東常會決議解除董事及其代表人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-06-11-1504-1jb8ii5","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"15:04:46","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-06-11 15:04，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-06-11-1502-1jb8ii5","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"15:02:13","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-06-11 15:02，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-06-11-1445-17j9geb","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"14:45:21","subject":"公告本公司與Samil Pharmaceutical簽署眼部術後炎症和疼痛治療新藥APP13007於越南市場之獨家授權合約","clause":"第10款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-06-11 14:45，「公告本公司與Samil Pharmaceutical簽署眼部術後炎症和疼痛治療新藥APP13007於越南市場之獨家授權合」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-06-11-1433-1j46v82","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-06-11","time":"14:33:23","subject":"公告本公司現金股利除息基準日","clause":"第14款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-06-11 14:33，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-06-11-1342-d2wj64","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"13:42:15","subject":"公告本公司股東會通過解除董事之競業禁止行為限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-06-11 13:42，「公告本公司股東會通過解除董事之競業禁止行為限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-06-11-1342-5pzdy7","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"13:42:01","subject":"公告本公司115年股東常會決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-06-11 13:42，「公告本公司115年股東常會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-06-11-1201-15e1v8f","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"12:01:47","subject":"本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-06-11 12:01，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-06-11-1035-isqttc","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"10:35:16","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-06-11 10:35，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2026-06-11-1027-1jb8ii5","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2026-06-11","time":"10:27:52","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2026-06-11 10:27，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-06-11-0825-12tllql","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-06-11","time":"08:25:59","subject":"台灣醣聯SPD8生物相似藥第三期臨床試驗完成解盲，結果符合解盲前預先定義之等效性標準","clause":"第53款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-06-11 08:25，「台灣醣聯SPD8生物相似藥第三期臨床試驗完成解盲，結果符合解盲前預先定義之等效性標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}